CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -55.54 % -70.67 % -90.19 % -28.79 % -
Y / Y Net Income Change 13.75 % 183.84 % -10.33 % 17.59 % -6.78 %
Net Income (TTM) in Millions 6,835 6,576 5,723 5,893 5,609
Return On Equity (TTM) 199.74 % 144.12 % 95.07 % 72.53 % 63.73 %
Total Ranking # 39 # 52 # 102 # 153 # 188
Equity (TTM) in Millions 3,653 2,419 916 6,700 8,217
Seq. Equity Change 51.01 % 164.08 % -86.33 % -18.46 % -0.36 %
Seq. Net Income Change 62.72 % -10.77 % -22.27 % 0.8 % 306.03 %


Roe Comment
Amgen Inc returned in III. Quarter 199.74 % on shareholder's equity, a new company high.

ROE improved compare to previous quarter, due to net income growth.

Within Healthcare sector 6 other companies have achieved higher return on equity. While Return on equity total ranking has impoved so far to 39, from total ranking in previous quarter at 52.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 2
Sector # 7
Overall # 39

Return On Equity Statistics
High Average Low
199.74 %
32.39 %
6.61 %
(Sep 30 2022)   (Dec 31 2017)


Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions 6,700 9,409 9,673 12,500 25,241
Y / Y Equity Change -28.79 % -2.73 % -22.62 % -50.48 % -15.51 %
Net Income in Millions 5,893 7,264 7,842 8,394 1,979
Y / Y Net Income Change -18.87 % -7.37 % -6.58 % 324.15 % -74.37 %
Return On Equity 87.96 % 77.2 % 81.07 % 67.15 % 7.84 %





Annual Roe Comment
Despite detoriation in net income, company improved ROE to in 2021, company improved ROE to 87.96 % compare to previous year.


Financial Statements
Amgen Inc 's Equity $ 3,653 Millions AMGN's Balance sheet
Amgen Inc 's Income $ 2,143 Millions Quarterly AMGN's Income Statement
AMGN's Income by Division See AMGN's Income by Division

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
AMGN's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for AMGN's Competitors
Return On Equity for Amgen Inc 's Suppliers
Roe for AMGN's Customers

You may also want to know
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Statistics
AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roi AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio



Companies with similar Return On Equity at Sep 30 2022, within Healthcare Sector ROE
Molecular Templates Inc   225.80 %
Bausch Health Companies Inc   211.35 %
Akili Inc   209.27 %
Amgen Inc   199.74 %
Dariohealth Corp   191.06 %
Chimerix inc   147.04 %
Harpoon Therapeutics Inc   128.27 %
Biofrontera Inc   105.90 %
Davita Inc   105.42 %
Halozyme Therapeutics Inc   95.77 %
Vicarious Surgical Inc   91.41 %
Biomx Inc   89.58 %
Dynavax Technologies Corporation  89.49 %
Abbvie Inc   85.92 %
Puma Biotechnology Inc   83.55 %
Maravai Lifesciences Holdings Inc   75.23 %
Aptevo Therapeutics Inc   74.95 %
Moderna Inc   70.03 %
Oncotelic Therapeutics Inc   69.60 %
Sensus Healthcare Inc   66.57 %
Selecta Biosciences Inc  66.02 %
Siga Technologies Inc  65.91 %
Eli Lilly And Company  64.45 %
Journey Medical Corporation  64.37 %
Kiniksa Pharmaceuticals Ltd   64.16 %
Harmony Biosciences Holdings inc   62.81 %
Science 37 Holdings Inc   60.98 %
Vir Biotechnology Inc   60.66 %
Innoviva Inc   58.51 %
Glucotrack Inc   57.65 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GENH's Profile

Stock Price

GENH's Financials

Business Description

Fundamentals

Charts & Quotes

GENH's News

Suppliers

GENH's Competitors

Customers & Markets

Economic Indicators

GENH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071